Status: Recruiting
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help identify patients who are at risk of pancreatic cancer.
Participants needed: 1,600
Trial details
Age: Up to 17Biological sex: AllType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: Mar 4, 2026Locations: 26
Eligibility criteria
All subjects/parents must sign an informed consent and/or assent indicating that... [+11]
Subjects must not have any significant medical illnesses that in the investigato...